Scarica l'app Stockscreener
2.00
3.38%
-0.07
Precedente Chiudi:
$2.07
Aprire:
$2.09
Volume 24 ore:
308.97K
Relative Volume:
1.36
Capitalizzazione di mercato:
$123.75M
Reddito:
$14.18M
Utile/perdita netta:
$-82.66M
Rapporto P/E:
-1.5385
EPS:
-1.3
Flusso di cassa netto:
$-50.80M
1 W Prestazione:
+16.96%
1M Prestazione:
+3.63%
6M Prestazione:
+1.01%
1 anno Prestazione:
+15.61%
Intervallo 1D:
$1.98
$2.09
Intervallo di 1 settimana:
$1.64
$2.09
Portata 52W:
$1.56
$2.625
Seer Inc Stock (SEER) Company Profile
Nome
Seer Inc
Settore
Industria
Telefono
650-453-0000
Indirizzo
3800 BRIDGE PARKWAY, SUITE 102, REDWOOD CITY
Confronta SEER con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SEER
Seer Inc
|
2.00 | 123.75M | 14.18M | -82.66M | -50.80M | -1.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.22 | 122.24B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
554.18 | 59.73B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
580.94 | 35.43B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
237.77 | 30.77B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
96.52 | 23.20B | 3.30B | -501.07M | 1.03B | -2.1146 |
Seer Inc Stock (SEER) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-07-05 | Ripresa | JP Morgan | Neutral |
| 2023-01-04 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-08-11 | Downgrade | JP Morgan | Overweight → Neutral |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2020-12-29 | Iniziato | BofA Securities | Neutral |
| 2020-12-29 | Iniziato | Cowen | Outperform |
| 2020-12-29 | Iniziato | JP Morgan | Overweight |
| 2020-12-29 | Iniziato | Morgan Stanley | Equal-Weight |
Mostra tutto
Seer Inc Borsa (SEER) Ultime notizie
Metagenomi Leads The Charge With These 3 Penny Stocks - simplywall.st
Seer : Immuneering to Present at the 24th Annual Needham Virtual Healthcare Conference - MarketScreener
Corient Private Wealth LLC Acquires 13,200 Shares of Seer, Inc. (NASDAQ:SEER) - Defense World
SEER LAUNCHES CARBON FOCUSED DIVISION TO PRODUCE LICENSED - GlobeNewswire
SEER LAUNCHES CARBON FOCUSED DIVISION TO PRODUCE LICENSED BIOCHAR, MONETIZE AND TOKENIZE ASSETS AND CARBON CREDITS AND DEVELOP TURBINE BLADE TREATMENT TECHNOLOGY - Yahoo
After Plunging -16.59% in 4 Weeks, Here's Why the Trend Might Reverse for Seer (SEER) - MSN
After Plunging -16.81% in 4 Weeks, Here's Why the Trend Might Reverse for Seer (SEER) - Yahoo Finance
Seer, Inc. (SEER) Reports Q4 Loss, Tops Revenue Estimates - MSN
Large Tools and Labs Optimistic at TD Cowen Health Conference By Investing.com - Investing.com Australia
Large Tools and Labs Optimistic at TD Cowen Health Conference - Investing.com India
Seer Inc (SEER) Q4 2024 Earnings Report Preview: What To Look Fo - GuruFocus.com
SEER, INC. : Results of Operations and Financial Condition (form 8-K) -January 25, 2021 at 04:40 pm EST - MarketScreener
Down -10.53% in 4 Weeks, Here's Why Seer (SEER) Looks Ripe for a Turnaround - Yahoo Finance
Y Intercept Hong Kong Ltd Acquires New Shares in Seer, Inc. (NASDAQ:SEER) - Defense World
Seer, Inc. Earnings Call: Mixed Sentiment and Optimistic Outlook - TipRanks
Seer, Inc. SEC 10-K Report - TradingView
Seer Full Year 2024 Earnings: In Line With Expectations - Yahoo Finance
Teams at Neptune Beach's Fletcher High win spots at national investment competition - MSN
Seer, Inc. (NASDAQ:SEER) Q4 2024 Earnings Call Transcript - Insider Monkey
Seer Inc (SEER) Q4 2024 Earnings Call Highlights: Navigating Rev - GuruFocus.com
Seer Inc (SEER) Q4 2024 Earnings Call Highlights: Navigating Revenue Decline with Strategic ... - Yahoo Finance
Seer, Inc. Reports 2024 Earnings and 2025 Outlook - TipRanks
Seer Inc (SEER) Q4 2024 Earnings: Revenue Beats at $4.0M, EPS Mi - GuruFocus.com
Seer Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings call transcript: Seer Inc. reports Q4 2024 revenue decline, stock rises - Investing.com
Seer Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Outlook - The Manila Times
Can Seer's New Proteomics Application Drive Its Ambitious 24% Revenue Growth Target? - StockTitan
Seer To Feature Proteomic Advancements in Cancer and RNA Therapy Research Among Other Findings at US HUPO 2025 - Technology Networks
Seer Inc (SEER) Q4 2024 Earnings Report Preview: What To Look For - Yahoo Finance
Seer Inc. (SEER) Earnings Preview: Q4 2024 Revenue Expected to Decline 11% - HPBL
Monash University's Proteomics & Metabolomics Platform Strengthens Partnerships with Seer and Thermo Fisher Scientific - Monash University
Seer to Participate in the TD Cowen 45th Annual Health Care Conference - GlobeNewswire
Can Seer's Proteomics Platform Disrupt Healthcare? Management Reveals Strategy Next Week - StockTitan
Seer (SEER) Expected to Announce Quarterly Earnings on Thursday - Defense World
Seer to Feature Proteomic Advancements in Cancer and RNA - GlobeNewswire
US Penny Stocks: 3 Picks With Market Caps As Low As $70M - Simply Wall St
Seer, Inc. to Showcase Innovations in Proteomics at US HUPO 2025 Annual Conference - Nasdaq
Revolutionary Cancer Therapy Platform: How Seer's Proteomics Technology is Reshaping Treatment Research - StockTitan
Peapod Lane Capital LLC Invests $991,000 in Seer, Inc. (NASDAQ:SEER) - MarketBeat
Seer to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025 - GlobeNewswire
Seer Proteomics Q4 Earnings Alert: Key Financial Metrics Unveiling February 27 - Stock Titan
Global X MSCI SuperDividend EAFE ETF (NASDAQ:EFAS) Shares Down 1.1% – What’s Next? - Armenian Reporter
Omid Farokhzad Sells 8,068 Shares of Seer, Inc. (NASDAQ:SEER) Stock - Armenian Reporter
Citrine Capital LLC Buys Shares of 24,875 Dimensional U.S. Equity ETF (NYSEARCA:DFUS) - Armenian Reporter
CSX Co. (NASDAQ:CSX) Shares Acquired by Glassy Mountain Advisors Inc. - Armenian Reporter
Seer Inc Azioni (SEER) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Seer Inc Azioni (SEER) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Farokhzad Omid | CEO AND CHAIR |
Feb 04 '25 |
Sale |
2.24 |
8,068 |
18,044 |
1,428,217 |
| Nishar Dipchand | Director |
Jun 14 '24 |
Sale |
1.78 |
12,109 |
21,512 |
79,457 |
4.44%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):